510(k) Report

510(k) · Cleared

Cleared

Medax Unipersonale SRL

K092338510(k) TraditionalCleared May 27, 2011661-day reviewClass II21 CFR 876.1075

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Medax Unipersonale Srl · KNW Instrument, Biopsy

Cleared on May 27, 2011 after a 661-day review. The FDA summary names no predicate by number. 2 later devices descend from it.

Decided
May 27, 2011
Review
661 days
Class
Class II
Product code
KNW
Recalls
None
Predicates
0

2 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2017: 1 descendant cleared2020: 1 descendant cleared2010201520202025
  1. This deviceK092338 Medax Unipersonale SRLMedax Unipersonale Srl · 2011
  2. Descendant · cites it directly · 1 of its ownK172344 Medax Biopsy Systems II (MEDONE, MEDCUT, MEDEM, MEDBONE, MEDLOCK)Medax Srl Unipersonale · 2017
  3. Descendant · 2 generations on · 0 of its ownK192099 MED-I Bone Marrow Aspiration Needle, MED-S Bone Marrow Aspiration…Medax Srl Unipersonale · 2020

Most influential descendants

Showing 2 of 2 · See all
  • K172344Medax Biopsy Systems II (MEDONE, MEDCUT, MEDEM, MEDBONE, MEDLOCK)Medax Srl Unipersonale · 2017 · cites it directly1descendant
  • K192099MED-I Bone Marrow Aspiration Needle, MED-S Bone Marrow Aspiration Needle, MED-L Bone…Medax Srl Unipersonale · 2020 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K092338Medax Unipersonale SRLMedax Unipersonale Srl2011—
+1K172344Medax Biopsy Systems II (MEDONE, MEDCUT, MEDEM, MEDBONE, MEDLOCK)Medax Srl Unipersonale2017—
+2K192099MED-I Bone Marrow Aspiration Needle, MED-S Bone Marrow Aspiration Needle…Medax Srl Unipersonale2020—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201710
202010
FIG. 1 — Lineage of K092338, 2011–2020Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KNW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KNW device

  1. #1 K260572 Marrow Marxmanscore 14.5 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

The FDA summary names no predicate by number.

What descends from it? (2)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K172344Medax Biopsy Systems II (MEDONE, MEDCUT, MEDEM, MEDBONE, MEDLOCK)Medax Srl Unipersonale20171

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K172344 (Medax Srl Unipersonale, 2017) has gone furthest, with 1 descendant of its own.

How does its category compare?

All KNW devices

KNW Instrument, Biopsy: FDA decisions, review times, recalls and adverse event reports over 20 years. 2011, this device’s year, is highlighted.

FDA decisions per year · KNW

12in 2025

2007: 62008: 42009: 62010: 32011: 102012: 72013: 32014: 82015: 102016: 92017: 82018: 72019: 52020: 82021: 92022: 82023: 72024: 52025: 122026 (partial year): 7
2007high 12 (2025) · low 3 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KNW

178in 2025

2007: 94 days median2008: 53 days median2009: 35 days median2010: 57 days median2011: 64 days median2012: 94 days median2013: 100 days median2014: 95 days median2015: 106 days median2016: 127 days median2017: 90 days median2018: 71 days median2019: 94 days median2020: 92 days median2021: 54 days median2022: 203 days median2023: 164 days median2024: 114 days median2025: 178 days median2026 (partial year): 29 days median
2007high 203 (2022) · low 35 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KNW

1in 2024

2007: 12008: 72009: 32010: 22011: 52012: 12013: 1, 1 Class I2014: 32016: 52017: 12019: 42021: 32022: 32023: 22024: 12026 (partial year): 4, 3 Class I
2007high 7 (2008) · low 0 (2015)2026

Class I (4 since 2007) Class II/III not classified

Adverse event reports per year · KNW

1,667in 2025

2007: 7662008: 3632009: 3512010: 1622011: 672012: 932013: 982014: 1932015: 5912016: 2972017: 7602018: 1,0122019: 4,1952020: 5,1202021: 1,0202022: 5352023: 9312024: 1,2832025: 1,667
2007high 5,120 (2020) · low 67 (2011)2025

MAUDE reports naming product code KNW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20076941766
20084537363
20096353351
20103572162
20111064567
2012794193
201331001 (1)98
20148953193
2015101060591
201691275297
20178901760
201877101,012
201959444,195
202089205,120
202195431,020
202282033535
202371642931
2024511411,283
20251217801,667
20267294 (3)—

What is it indicated for?

Device name: Universal Duo. Intended use: to be used for histological biopsy on soft tissues. Device name: Neoxus. Intended use: to retrieve bone marrow and bone samples from iliac crest. Device name: Cage. Intended use: to retrieve bone marrow and bone samples from iliac crest. Device name: Velox. Intended use: histological biopsy on soft tissues Device name: Velox 2. Intended use: histolegical biopsy on soft tissues Device name: Universal Plus.…

Read the full statement (184 words)

Device name: Universal Duo. Intended use: to be used for histological biopsy on soft tissues.

Device name: Neoxus. Intended use: to retrieve bone marrow and bone samples from iliac crest.

Device name: Cage. Intended use: to retrieve bone marrow and bone samples from iliac crest.

Device name: Velox. Intended use: histological biopsy on soft tissues

Device name: Velox 2. Intended use: histolegical biopsy on soft tissues

Device name: Universal Plus. Intended use: histological biopsy on soft tissues.

Device name: Universal. Intended use: histological biopsy on soft tissues.

Device name: Perfectus. Intended use: aspiration bone marrow from sternum or iliac crest.

Device name: Lux. Intended use: histological biopsy on soft tissues

Device name: Lux 2. Intended use: histological biopsy on soft tissues

Device name: Hepax. Intended use: histological and cytological biopsies of soft tissue

Device name: FNA (Chiba /Quincke /Turner/ Westcott / Franseen). Intended use: Aspiration needle for cyto - histological biopsies on soft tissue.

Device name: Facile. Intended use: histological biopsy on soft tissues

Device name: Cesar. Intended use: histological biopsy on soft tissues

Device name: Nextage. Intended use: histological biopsy on soft tissues

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K092338: Medax Unipersonale SRL.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K092338

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026